2-[2-[2-[[2-[2-(2-aminoethoxy)ethoxy]acetyl]amino]ethoxy]ethoxy]acetic acid
|
815-071-0
|
1143516-05-5
|
|
Notified C&L
|
View details
|
PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,17-DIHYDROXY-21-IODO-16-METHYL-,(11.BETA.,16.BETA.)-
|
815-072-6
|
2467-66-5
|
|
Notified C&L
|
View details
|
3-(4-Amino-1-oxoisoindolin-2-yl)-piperidine-2,6-dione hydrochloride
|
815-073-1
|
1243329-97-6
|
|
Notified C&L
|
View details
|
PREGNA-1,4-DIENE-3,20-DIONE,9-FLUORO-11,17-DIHYDROXY-16-METHYL-21-((METHYLSULPHONYL)OXY)-, (11.BETA.,16.BETA.)-
|
815-074-7
|
1881-66-9
|
Repr. 1B
STOT RE 2
STOT RE 2
|
Notified C&L
|
View details
|
PYRIDINIUM,1-((7-AMINO-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4,2,0)OCT-2-EN-3-YL)METHYL) -, HYDROXIDE, INNER SALT, HYDROCHLORIDE, (6R-TRANS)
|
815-075-2
|
96752-43-1
|
Skin Sens. 1
Resp. Sens. 1
|
Notified C&L
|
View details
|
21-BROMO-3-BETA,17-DIHYDROXY-16-METHYLENE-5-ALPHA-PREGNA-9(11)-EN-20-ONE
|
815-076-8
|
13712-10-2
|
|
Notified C&L
|
View details
|
(3-BETA-5-ALPHA,25R)-3-HYDROXY-SPIROST-9(11)-EN-12-ONE * 1786 (GW ACN)
|
815-077-3
|
3514-26-9
|
|
Notified C&L
|
View details
|
1R-CIS)-(4-(HYDROXYMETHYL)-2-CYCLOPENTEN-1-YL)CARBAMIC ACID,1,1-DIMETHYLETHYL ESTER
|
815-078-9
|
168960-18-7
|
|
Notified C&L
|
View details
|
(5-(3-chlorophenyl)-3-hydroxypicolinoyl)glycine
|
815-079-4
|
1000025-07-9
|
|
Notified C&L
|
View details
|
1,3-Dicaffeoylquinic acid
|
815-081-5
|
19870-46-3
|
|
Notified C&L
|
View details
|
Isochlorogenic acid A
|
815-082-0
|
2450-53-5
|
|
Notified C&L
|
View details
|
Tert-butyl N-[(1S,3R)-3-acetylcyclopentyl]carbamate
|
815-083-6
|
204913-01-9
|
|
REACH registration C&L
|
View details
|
Zirconium oxide, hafnium and ytterbium doped
|
945-888-9
|
|
|
REACH registration C&L
|
View details
|
(3S,6S,7R,8R)-8-benzyl-3-{[(4-methoxy-3-{[(2-methylpropanoyl)oxy]methoxy}pyridin-2-yl)carbonyl]amino}-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate
|
815-084-1
|
517875-34-2
|
Aquatic Acute 1
Aquatic Chronic 1
|
Notified C&L
|
View details
|
5-ACETOXY-(1,3)OXATHIOLANE-2-CARBOXYLIC ACID
|
815-085-7
|
147027-43-8
|
Acute Tox. 4
Skin Irrit. 2
Skin Sens. 1
Eye Dam. 1
|
Notified C&L
|
View details
|
Reaction products of slack wax (petroleum), oxidized, esterified with n-butanol
|
945-889-4
|
|
|
REACH registration C&L
|
View details
|
4-THIAZOLEACETIC ACID,2-AMINO-.ALPHA.-((2-(1,1-DIMETHYLETHOXY)-1,1-DIMETHYL-2-OXOETHOXY)IMINO)-, ANHYDRIDE WITH DIETHYL HYDROGEN PHOSPHATE, (Z)-
|
815-086-2
|
179258-52-7
|
Acute Tox. 3
Skin Sens. 1
Eye Dam. 1
Acute Tox. 2
STOT RE 2
STOT RE 2
Aquatic Chronic 3
|
Notified C&L
|
View details
|
tris(2-hydroxyethyl)ammonium 6-(3,5,5-trimethylhexanamido)hexanoate
|
701-138-0
|
242482-67-3
|
|
REACH registration C&L
|
View details
|
9 BETA ARABINOFURANOSYLGUANINE
|
815-087-8
|
38819-10-2
|
Muta. 2
Carc. 2
Repr. 2
STOT RE 1
STOT RE 1
|
Notified C&L
|
View details
|
1H-Pyrrolo[1,2-a]imidazole-2,5(3H,6H)-dione, dihydro-, (7aR)
|
815-089-9
|
151062-30-5
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
3-{3,4-DIFLUORO-5-[(R)-2-HYDROXY-3-(2-INDAN-2-YL-1,1-DIMETHYL-ETHYLAMINO)-PROPOXY]-PHENYL}-PROPIONIC ACID
|
815-090-4
|
753449-67-1
|
|
Notified C&L
|
View details
|
3-[(2R)-3-[[2-(2,3-DIHYDRO-1H-INDEN-2-YL)-1,1-DIMETHYLETHYL]AMINO]-2-HYDROXYPROPOXY]-4,5-DIFLUOROBENZENEPROPANOIC ACID, HYDROCHLORIDE
|
815-092-5
|
702686-96-2
|
|
Notified C&L
|
View details
|
Monoclonical antibody derivative MK-5609
|
|
|
|
Notified C&L
|
View details
|
1-(ACETYLOXY)ETHYL ESTER(2R,6R,7R)-3-[[(AMINOCARBONYL)OXY]METHYL]-7-[[(2Z)-2-(2-FURANYL)-2-(METHOXYIMINO)ACETYL]AMINO]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-3-ENE-2-CARBOXYLATE
|
815-093-0
|
152985-09-6
|
Skin Sens. 1
Resp. Sens. 1
|
Notified C&L
|
View details
|
1-{[3-(4-{[(2R)-4-[5-FLUORO-2-(METHYLOXY)PHENYL]-2-HYDROXY-4-METHYL-2-(TRIFLUOROMETHYL)PENTYL]AMINO}-6-METHYL-1H-INDAZOL-1-YL)PHENYL]CARBONYL}-D-PROLINAMIDE
|
815-094-6
|
955946-56-2
|
Repr. 1B
STOT RE 2
STOT RE 2
|
Notified C&L
|
View details
|
N-[4-CHLORO-2-HYDROXY-3-[(3S)-3-PIPERIDINYLSULFONYL]PHENYL]-N'-(3-FLUORO-2-METHYLPHENYL)UREA
|
815-095-1
|
954126-98-8
|
Repr. 2
STOT RE 2
STOT RE 2
|
Notified C&L
|
View details
|
Chloro-fluorophenyl pyridinyl derivative
|
|
|
|
Notified C&L
|
View details
|
6,6'-(Ethane-1,2-diylbis(azanediyl))bis(dibenzo[c,e][1,2]oxaphosphinine-6-oxide)“
|
815-096-7
|
1421927-53-8
|
|
REACH registration C&L
|
View details
|
4-(hydroxymethyl)benzaldehyde
|
815-097-2
|
52010-97-6
|
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
|
Notified C&L
|
View details
|
3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole acetate
|
815-098-8
|
68808-54-8
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
Muta. 1B
|
Notified C&L
|
View details
|
Methyl azetidine-3-carboxylate hydrochloride
|
815-099-3
|
100202-39-9
|
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
|
Notified C&L
|
View details
|
5,6-Difluoro-2,1,3-benzothiadiazole
|
815-100-7
|
1293389-28-2
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1-Methylcyclobutane-1-carboxylic acid
|
815-101-2
|
32936-76-8
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
N-(3-Trimethoxysilylpropyl)pyrrole
|
815-102-8
|
80906-67-8
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
5-Fluoro-2,3-diaminopyridine
|
815-103-3
|
212268-13-8
|
Acute Tox. 4
Acute Tox. 4
Skin Irrit. 2
Eye Irrit. 2
Acute Tox. 4
STOT SE 3
|
Notified C&L
|
View details
|
1-[3-[4-(4-cyanophenyl)-heteromonocycle-2-yl]-2-(2,5-difluorophenyl)-2-hydroxybutyl]-heteromonocycle-4-ium chloride
|
|
|
|
Notified C&L
|
View details
|
2-(Aminomethyl)-4-fluorobenzeneboronic acid, N-BOC protected
|
815-104-9
|
850568-64-8
|
Skin Irrit. 2
Eye Irrit. 2
STOT SE 3
|
Notified C&L
|
View details
|
2,2',2"-Nitrilotris(ethanolato)(buta-1,3-dien-2-yl)silane
|
815-105-4
|
1026785-83-0
|
|
Notified C&L
|
View details
|
(2R,5R)-1-[2-[(2R,5R)-2,5-diphenylphospholan-1-yl]ethyl]-2,5-diphenylphospholane
|
815-107-5
|
528565-79-9
|
|
Notified C&L
|
View details
|
Essential oil of Canarium commune (Burseraceae) obtained from gum by steam distillation
|
945-898-3
|
|
Flam. Liq. 3
Asp. Tox. 1
Skin Irrit. 2
Skin Sens. 1B
Aquatic Chronic 2
|
REACH registration C&L
|
View details
|
Reaction products of 2-amino-4,6-dinitrophenol, 4-amino-5-hydroxy 2,7-naphthalenedisulfonic acid, 4-nitrobenzenamine and resorcinol, sodium salts
|
701-140-1
|
|
|
REACH registration C&L
|
View details
|
2,5-Dioxopyrrolidin-1-yl N2,N6-bis(tert-butoxycarbonyl)-L-lysinate
|
815-108-0
|
30189-36-7
|
|
Notified C&L
|
View details
|
(11bR)-N,N-Bis[(R)-(-)-1-(2-methoxyphenyl)ethyl]dinaphtho[2,1-d:1',2'-f][1,3,2] dioxaphosphepin-4-amine
|
815-109-6
|
736158-72-8
|
|
Notified C&L
|
View details
|
Bis(3-sulfonatophenyl)(2-trifluoromethylphenyl)phosphine, disodium dihydrate
|
815-110-1
|
1289463-84-8
|
|
Notified C&L
|
View details
|
5-Phenyl-5H-benzo[b]phosphindole
|
815-111-7
|
1088-00-2
|
|
Notified C&L
|
View details
|
[2,6-Di-i-propoxyphenyl]dicyclohexylphosphonium tetrafluoroborate
|
815-112-2
|
1268824-70-9
|
|
Notified C&L
|
View details
|
[2-Dicyclohexylphosphino-3-methoxy-N-methyl-N-phenylbenzenamine
|
815-113-8
|
1398565-95-1
|
|
Notified C&L
|
View details
|
1-Diphenylphosphino-1'-(di-t-butylphosphino)ferrocene
|
815-114-3
|
95408-38-1
|
|
Notified C&L
|
View details
|
bis(adamantan-1-yl)(butyl)phosphane; {2'-amino-[1,1'-biphenyl]-2-yl}palladio methanesulfonate
|
815-115-9
|
1651823-59-4
|
Skin Irrit. 2
Eye Irrit. 2A
STOT SE 3
Aquatic Chronic 3
|
Notified C&L
|
View details
|
Tris(4,4'-dimethyl-2,2'-bipyridine)ruthenium(II) hexafluorophosphate
|
815-116-4
|
83605-44-1
|
|
Notified C&L
|
View details
|
|
|
|
|
|
|